Want to join the conversation?
Brad Reback from Stifel Nicolaus asks about the CapEx requirements for the business in FY17. $ORCL CEO Safra Catz said overall CapEx should be little bit more than it is in FY16. All of that would be on the real estate side as the company is building out its campus in Texas. In cloud CapEx, it will go up a bit but not near where it was in FY15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?